Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer
Galina Semenova, Sander B. Frank, Ruth F. Dumpit, Wanting Han, Ilsa M. Coleman, Roman Gulati, Canan D. Dirican, Tarana Arman, Jessica Maruwan, Colm M. Morrissey, Michael C. Haffner, Peter S. Nelson, John K. Lee
Journal of Clinical Investigation · Jun 23, 2026Peer-reviewedCancer Biology